Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
---|
08/09/2012 | US20120202850 Method for treating thrombosis and inhibiting platelet aggregation with 21-(s)-argatroban |
08/09/2012 | US20120202848 Therapy of autoimmune colitis using a tip60 inhibitor |
08/09/2012 | US20120202847 Novel Tetrahydroisoquinoline Compounds |
08/09/2012 | US20120202810 Substituted 4-aminocyclohexane derivatives |
08/09/2012 | US20120202806 Novel Pyrimidine- And Triazine-Hepcidine Antagonists |
08/09/2012 | US20120202790 [6,6] and [6,7]-bicyclic gpr119 g protein-coupled receptor agonists |
08/09/2012 | US20120202782 Compounds and compositions as itpkb inhibitors |
08/09/2012 | US20120202763 Methods for treating cancer and non-neoplastic conditions |
08/09/2012 | US20120202758 Core 2glcnac-t inhibitors |
08/09/2012 | US20120202733 Inhibition of trem receptor signaling with peptide variants |
08/09/2012 | US20120202273 Enzymatic Conversion Of Blood Group A, B, And AB Red Blood Cells Using Alpha-N-Acetylgalactosaminidases and Alpha-Galactosidases With Unique Substrate Specificities And Kinetic Properties |
08/09/2012 | US20120202243 IN Vivo Incorporation of Unnatural Amino Acids |
08/09/2012 | US20120201912 Substances for reducing occurrence of major cardiac events comprising omega-3 polyunsaturated fatty acid or derivatives thereof and high-monacolin k content red yeast rice extract |
08/09/2012 | US20120201888 Pharmaceutical Compositions |
08/09/2012 | US20120201884 Extracts, fractions and compositions comprising acetogenins and their applications |
08/09/2012 | US20120201872 Liposomes comprising a calcium phosphate-containing precipitate |
08/09/2012 | US20120201867 Drug delivery from embolic agents |
08/09/2012 | US20120201864 Method |
08/09/2012 | US20120201858 Multiple-arm peptide compounds, methods of manufacture and use in therapy |
08/09/2012 | US20120201857 Transdermal delivery system for therapeutics |
08/09/2012 | US20120201831 Human antibodies that bind human il-12 and methods for producing |
08/09/2012 | US20120201818 Treatment of multiple sclerosis |
08/09/2012 | US20120201816 Lactam-containing compounds and derivatives thereof as factor xa inhibitors |
08/09/2012 | US20120201805 Composition for improving blood circulation and alleviating cold hands and feet, containing fermented tea extract |
08/09/2012 | US20120201784 Long lasting drug formulations |
08/09/2012 | US20120201756 Plasma kallikrein binding proteins |
08/09/2012 | CA2817841A1 1,4 oxazines as bace1 and/or bace2 inhibitors |
08/08/2012 | EP2484697A1 Anti-podoplanin antibody, and pharmaceutical composition containing anti-podoplanin antibody |
08/08/2012 | EP2484669A1 Novel phenol derivative |
08/08/2012 | EP2484369A1 Manufacturing method for dried earthworm powder |
08/08/2012 | EP2484366A1 Idrabiotaparinux for the treatment of pulmonary embolism and for the secondary prevention of venous thromboembolic events |
08/08/2012 | EP2066680B1 Triphenylphosphonium thionitrite nitric oxide donors |
08/08/2012 | CN202366204U Traditional Chinese medicine bag for treating liver ascites |
08/08/2012 | CN102628044A RNAi modulation of APOB and uses thereof |
08/08/2012 | CN102628029A Thalassemia-induced multipotent stem cell as well as preparation method and application thereof |
08/08/2012 | CN102627680A Ginsenoside Rg1 compound and pharmaceutical composition containing the same |
08/08/2012 | CN102627676A C-aryl glucoside sglt2 inhibitors and method |
08/08/2012 | CN102627656A Process for extraction and separation of ginkgolides A, B, C, J, M and bilobalide |
08/08/2012 | CN102627620A One type of benzofuran derivatives and medical application thereof |
08/08/2012 | CN102626517A Method to modulate hematopoietic stem cell growth |
08/08/2012 | CN102626506A Traditional Chinese medicine for curing seroperitoneum |
08/08/2012 | CN102626493A Arborvitae leaf-flos sophorae-thistle-cogongrass rhizome decoction for curing peptic ulcer bleeding |
08/08/2012 | CN102626487A Chinese medicinal pill for treating wind-cold damp pathogen and preparation method thereof |
08/08/2012 | CN102626472A Medicine for treating acute cerebral hemorrhage and preparation method thereof |
08/08/2012 | CN102626462A Pharmaceutical composition with blood-enriching and leukogenic efficacy |
08/08/2012 | CN102626450A Method for preparing total diterpenoids alkaloid in monkshood |
08/08/2012 | CN102626449A Capsule for treating apoplexy hemiplegia |
08/08/2012 | CN102626427A Ginkgo dipyridamole composition and preparation method of preparation thereof |
08/08/2012 | CN102626419A Compound preparation for treating edema diseases of pigs and preparation method thereof |
08/08/2012 | CN102626391A Aliskiren-hydrochlorothiazide drug combination liposome solid preparation |
08/08/2012 | CN102626388A Liposome solid preparation of ozagrel |
08/08/2012 | CN102626383A Bilobalide injection and preparation method thereof |
08/08/2012 | CN102626382A Method for preparing sinomenine hydrochloride infusion solution and freeze-dried powder injection |
08/08/2012 | CN102205115B Application of ulinastatin serving as rescue auxiliary medicament for toxic shock caused by acute abdomen |
08/08/2012 | CN102167752B Preparation method of water-soluble soybean polysaccharide ferrous coordination compound |
08/08/2012 | CN101889079B A method for constructing human placental mesenchymal cells library which is suitable for clinical applicationc |
08/08/2012 | CN101822690B Composition of dextran 40 and sodium lactate Ringer' solution and preparation method |
08/08/2012 | CN101590192B Traditional Chinese medicine combination for treating leukemia and preparation method thereof |
08/08/2012 | CN101553466B New crystalline forms |
08/08/2012 | CN101543298B Rutin chewing agent and method for preparing same |
08/08/2012 | CN101485791B Application of Ampelopsis grossedentata total flavone in preparing medicament for preventing and treating adverse reaction of tumor chemoradiotherapy |
08/08/2012 | CN101090731B Use of bombesin/gastrin-releasing peptide antagonists for the treatment of inflammatory conditions, acute lung injury and bipolar disorder |
08/07/2012 | US8236339 Therapeutic delivery of carbon monoxide |
08/07/2012 | US8236048 Drug/drug delivery systems for the prevention and treatment of vascular disease |
08/07/2012 | CA2563401C Imidazole derivatives used as tafia inhibitors |
08/07/2012 | CA2445421C Von willebrand factor (vwf)-cleaving protease |
08/07/2012 | CA2430557C Highly branched soluble glucose polymers and process of obtaining same |
08/02/2012 | WO2012103512A2 Expanded utility of red cell-derived microparticles (rmp) for treatment of bleeding |
08/02/2012 | WO2012102937A2 Compounds that expand hematopoietic stem cells |
08/02/2012 | WO2012102555A2 Fucoidan for thrombolysis, derived from seaweed |
08/02/2012 | WO2012101747A1 Tie2 ACTIVATOR, AGENT FOR MATURING, NORMALIZING OR STABILIZING BLOOD VESSELS, AGENT FOR STABILIZING LYMPHATIC VESSELS, PREPARATION FOR PREVENTING AND REDUCING WRINKLES, AND PREPARATION FOR REDUCING AND PREVENTING SWELLING |
08/02/2012 | WO2012101442A1 Process |
08/02/2012 | WO2012101181A1 Compositions and methods for cell transplantation |
08/02/2012 | WO2012100654A1 Ribofuranosyl purine compound, preparation method therefor, and use thereof |
08/02/2012 | US20120196924 METHODS AND PRODUCTS FOR EXPRESSION OF MICRO RNAs |
08/02/2012 | US20120196909 Deferacirox dispersible tablets |
08/02/2012 | US20120196884 Urea substituted sulphonamide derivatives |
08/02/2012 | US20120196869 Pyrrolopyrazine-spirocyclic piperidine amides as modulators of ion channels |
08/02/2012 | US20120196853 Novel Quinoline-Hepcidine Antagonists |
08/02/2012 | US20120196844 Compounds and compositions as modulators of gpr119 activity |
08/02/2012 | US20120196825 Compositions and methods for modulating the immune system |
08/02/2012 | US20120196807 Kidney-targeting drug delivery agent comprising recombinant gelatin |
08/02/2012 | US20120196806 Anticoagulant and composition for preventing thrombus containing poly-gamma-glutamic acid |
08/02/2012 | US20120196789 Peptide based peroxidase inhibitors and methods of using same |
08/02/2012 | US20120195987 Substances for reducing occurrence of major cardiac events comprising epa or derivatives thereof, optionally, dha or derivatives thereof and monacolin k |
08/02/2012 | US20120195976 Methods of treating inflammation by administration of heme oxygenase-1 and products of heme degradation |
08/02/2012 | US20120195965 Solid dosage form comprising a fibrate |
08/02/2012 | US20120195910 Anti-pcsk9 antibodies and methods of use |
08/02/2012 | US20120195908 Combinatorial therapy |
08/02/2012 | US20120195871 Stable aqueous suspension |
08/02/2012 | US20120195826 Injectable biomaterial |
08/02/2012 | DE102011003315A1 New 1H-pyrazolo(3,4-b)pyridine compounds are guanylate cyclase stimulators useful for treating and/or preventing e.g. heart failure, angina pectoris, hypertonia, pulmonary hypertonia, ischemia, vascular disease, and fibrotic disorder |
08/02/2012 | CA2825252A1 Compositions and methods for cell transplantation |
08/02/2012 | CA2824931A1 Process |
08/01/2012 | EP2481738A1 Maleic acid salt and crystal thereof |
08/01/2012 | EP2481398A1 Slow-release cilostazol tablet having an improved elution rate and minimal side effects |
08/01/2012 | EP2480229A2 Zinc-containing compositions for the treatment of diseases, illnesses and syndromes associated with exposure to pore forming toxins |
08/01/2012 | EP2188016B1 Use of octreotide as a therapeutic agent |
08/01/2012 | EP1405852B1 Diamine derivatives |
08/01/2012 | CN102625712A Unit dose formulation of antidotes for factor Xa inhibitors and methods of using the same |